These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38006726)

  • 1. Hsa_circ_0013561 promotes progression of nasopharyngeal carcinoma by activating JAK2/STAT3 signaling pathway.
    Kaisai T; Mantang Z; Tailei Y; Liying Z; Xiaoping C; Mingming J; Yi Z
    Braz J Otorhinolaryngol; 2024; 90(1):101362. PubMed ID: 38006726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.
    Zheng YQ; Cui YR; Yang S; Wang YP; Qiu YJ; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):613-621. PubMed ID: 30720169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA Hsa_circ_0066755 as an Oncogene via sponging miR-651 and as a Promising Diagnostic Biomarker for Nasopharyngeal Carcinoma.
    Wang J; Kong J; Nie Z; Chen D; Qiang J; Gao W; Chen X
    Int J Med Sci; 2020; 17(11):1499-1507. PubMed ID: 32669952
    [No Abstract]   [Full Text] [Related]  

  • 4. Hsa_circ_001193 regulates proliferation and apoptosis of nasopharyngeal carcinoma cells through targeting mir-496.
    Ke KJ; Wang CY; Li P; Huang XW; Zhang SL; Li X; Cui XF
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3069-3076. PubMed ID: 32271424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2/STAT3 signaling pathway via miR-375.
    Li L; Xiao C; He K; Xiang G
    IUBMB Life; 2021 Sep; 73(9):1153-1165. PubMed ID: 34148288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa_circ_0000345 inhibits cell proliferation, migration and invasion of nasopharyngeal carcinoma cells via miR-513a-3p/PTEN axis.
    Jiang C; Li H; Liu F; Shi L; Liu J; Li Y
    J Physiol Sci; 2022 May; 72(1):10. PubMed ID: 35545766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p.
    Zhu L; Liu Y; Yang Y; Mao XM; Yin ZD
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2817-2826. PubMed ID: 31002133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hsa_circ_0136839 regulates the malignant phenotypes of nasopharyngeal carcinoma via the Wnt/β-catenin signaling pathway.
    Huang J; Cai Y; Guo L; Huang W; Yan J; Lai J; Wang Y; Jiang D; Peng L
    Pathol Res Pract; 2023 May; 245():154433. PubMed ID: 37023555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0081534 facilitates malignant phenotypes by sequestering miR-874-3p and upregulating FMNL3 in nasopharyngeal carcinoma.
    He J; Chen S; Wu X; Jiang D; Li R; Mao Z
    Auris Nasus Larynx; 2022 Oct; 49(5):822-833. PubMed ID: 35428519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0000523 regulates miR-1184/COL1A1/PI3K/Akt pathway to promote nasopharyngeal carcinoma progression.
    Huang P; Li M; Tang Q; Jiang K; Luo Y
    Apoptosis; 2022 Oct; 27(9-10):751-761. PubMed ID: 35759163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3.
    Yin L; Chen J; Ma C; Pei S; Du M; Zhang Y; Feng Y; Yin R; Bian X; He X; Feng J
    Cell Death Dis; 2020 Jul; 11(7):562. PubMed ID: 32703944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of IL-6 and JAK2/STAT3 signaling pathway with prognosis of nasopharyngeal carcinoma patients.
    Zhuang M; Ding X; Song W; Chen H; Guan H; Yu Y; Zhang Z; Dong X
    Aging (Albany NY); 2021 Jun; 13(12):16667-16683. PubMed ID: 34165442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXK1 regulates epithelial-mesenchymal transition and radiation sensitivity in nasopharyngeal carcinoma via the JAK/STAT3 signaling pathway.
    Duan L; Huang J; Zhang Y; Pi G; Ying X; Zeng F; Hu D; Ma J
    Genes Genomics; 2023 Jun; 45(6):749-761. PubMed ID: 37043129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa_circ_0081534 increases the proliferation and invasion of nasopharyngeal carcinoma cells through regulating the miR-508-5p/FN1 axis.
    Li S; Wang Q
    Aging (Albany NY); 2020 Oct; 12(20):20645-20657. PubMed ID: 33082297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA‑19b inhibitors can attenuate the STAT3 signaling pathway in NPC C666‑1 cells.
    Bian LH; Duan JL; Zhou C; Shen GW; Wang XY; Yang Y; Zhang XL; Xiao SJ
    Mol Med Rep; 2020 Jul; 22(1):51-56. PubMed ID: 32377721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G3BP1 Interact with JAK2 mRNA to Promote the Malignant Progression of Nasopharyngeal Carcinoma via Activating JAK2/STAT3 Signaling Pathway.
    Zhan Y; Wang W; Wang H; Xu Y; Zhang Y; Ning Y; Zheng H; Luo J; Yang Y; Zang H; Zhou M; Fan S
    Int J Biol Sci; 2024; 20(1):94-112. PubMed ID: 38164170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the regulatory role of the circ_0004788/miR-515-5p/FGF2 network in nasopharyngeal carcinoma development.
    Li D; Li X; Fan G; Bian G
    Head Neck; 2022 Jul; 44(7):1631-1645. PubMed ID: 35460538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
    Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.